MTOR and nasal cavity polyp: Rapamycin inhibits the PI3K/Akt/mTOR pathway, thereby inhibiting the differentiation of fibroblasts in nasal polyps and the production of collagen and extracellular matrix, and attenuating the occurrence of tissue remodeling.19